Signant Health Joins the Association of Clinical Research Organizations (ACRO) to Add a Technology Perspective to Conversations with Legislators and Industry Leaders about the Future of Clinical Research
November 21, 2019 – Clinical Trials –
PHILADELPHIA, PA – November 21, 2019:
Signant Health announced today that it has joined the non-profit Association of Clinical Research Organizations (ACRO).
ACRO, a global coalition of research and technology companies, makes it their
mission to advocate as the collective voice of the innovative clinical research
industry to regulators and policymakers, educating stakeholders and shaping policies
that foster efficient, effective and safe conduct of clinical research.
Signant Health announced today that it has joined the non-profit Association of Clinical Research Organizations (ACRO).
ACRO, a global coalition of research and technology companies, makes it their
mission to advocate as the collective voice of the innovative clinical research
industry to regulators and policymakers, educating stakeholders and shaping policies
that foster efficient, effective and safe conduct of clinical research.
Founded in 2002, ACRO supports members by
elevating their positions and goals to legislators, ensuring regulators such as
the FDA, NIH, EMA, and lawmakers understand the nuances and intricacies faced
by todayís clinical trial organizations. This work influenced some of the more
important recent clinical trial regulations such as the 21st Century
Cures Act and EU Clinical Trial Regulation.
elevating their positions and goals to legislators, ensuring regulators such as
the FDA, NIH, EMA, and lawmakers understand the nuances and intricacies faced
by todayís clinical trial organizations. This work influenced some of the more
important recent clinical trial regulations such as the 21st Century
Cures Act and EU Clinical Trial Regulation.
As the 13th member company
elected into ACRO, Signant Health joins as one of the industryís premier eCOA,
eConsent, and clinical trial technology companies.
elected into ACRO, Signant Health joins as one of the industryís premier eCOA,
eConsent, and clinical trial technology companies.
Mike Nolte, CEO of Signant Health, said ‘As
a technology provider, Signant brings a unique perspective to ACRO, promoting
collaboration across the industry to achieve our shared responsibility for
advancing patient-centric clinical research. Aligned with our strategy and
values, ACRO has prioritized conversations around patient safety, privacy, and technologyís
impact on clinical trials, and we are excited to join with ACRO and its member
companies to support policy and investment that ensure safe and efficient
trials for patients everywhere.’
a technology provider, Signant brings a unique perspective to ACRO, promoting
collaboration across the industry to achieve our shared responsibility for
advancing patient-centric clinical research. Aligned with our strategy and
values, ACRO has prioritized conversations around patient safety, privacy, and technologyís
impact on clinical trials, and we are excited to join with ACRO and its member
companies to support policy and investment that ensure safe and efficient
trials for patients everywhere.’
‘Signant
Healthís mission – ensuring the patient remains at the forefront of clinical
trial design and execution, while advancing the efficiency of the clinical
trial enterprise – is one shared by the member companies of ACRO,’ said
Executive Director, Doug Peddicord. ‘We are extremely pleased to welcome
Signant as our newest member and look forward to working together to move our
industry forward.’
Healthís mission – ensuring the patient remains at the forefront of clinical
trial design and execution, while advancing the efficiency of the clinical
trial enterprise – is one shared by the member companies of ACRO,’ said
Executive Director, Doug Peddicord. ‘We are extremely pleased to welcome
Signant as our newest member and look forward to working together to move our
industry forward.’
To learn more about Signant Health visit https://signanthealth.com. For
further information on ACRO, please visit https://www.acrohealth.org.
further information on ACRO, please visit https://www.acrohealth.org.
Who Is Signant Health?
The best technology succeeds in
the background. Signant Health provides solutions that simplify every step of
the patient journey to make it easier for people to participate in, and for
sites and study teams to run, clinical trials. Signant unites eCOA, eConsent,
Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the
industryís most comprehensive patient-centric suite – an evolution built on
more than 20 years of proven clinical research technology. Our intense focus on
the patient experience, deep therapeutic area expertise and global operational
scale enable hundreds of sponsors and CROs (including all Top 20 pharma) to
extend the reach of drug development, expand patient opportunities and improve
data quality – helping them bring life-changing therapies to our families and
communities around the world. Take a significant step toward patient-centricity
at signanthealth.com.
the background. Signant Health provides solutions that simplify every step of
the patient journey to make it easier for people to participate in, and for
sites and study teams to run, clinical trials. Signant unites eCOA, eConsent,
Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the
industryís most comprehensive patient-centric suite – an evolution built on
more than 20 years of proven clinical research technology. Our intense focus on
the patient experience, deep therapeutic area expertise and global operational
scale enable hundreds of sponsors and CROs (including all Top 20 pharma) to
extend the reach of drug development, expand patient opportunities and improve
data quality – helping them bring life-changing therapies to our families and
communities around the world. Take a significant step toward patient-centricity
at signanthealth.com.
Contact: media@signanthealth.com, +1 267.498.2350
